-
Findings substantiate the VeriQ system’s ability to improve outcomes for coronary artery bypass surgery and contain costs.
Read the full article. Published: 1/11/2012
-
“The VeriQ system is associated with an estimated cost saving of £115 per patient compared with clinical assessment, when it is used routinely for assessing coronary artery bypass grafts during surgery.”
Read the full article. Published: 11/17/2011
-
A new transit time flow measurement (TTFM) probe line specifically designed for vascular surgery is being launched at the annual conference of the European Society for Vascular Surgery (ESVS).
Read the full article. Published: 9/30/2011
-
Medistim has signed contracts with three hospitals in the US and achieved its first revenues from the company's new product VeriQC.
Read the full article. Published: 9/13/2011
-
Sales increased with 4.6 % to MNOK 42.2 for the
second quarter. Operating profit ended at MNOK 8.8
(MNOK 9.5).
Read the full article. Published: 9/1/2011
-
MediStim ASA (OSE: MEDI), a Norwegian Medtech company that develops and commercializes medical equipment for use within cardiac and vascular surgery, as well as other surgical fields, announces that the company has entered into a license agreement with Freebit AS.
Read the full article. Published: 9/1/2011
-
MediStim ASA (OSE: MEDI), a Norwegian Medtech company that develops and commercializes medical equipment for use within cardiac and vascular surgery, as well as other surgical fields, announces that the company is strengthening its commercial organization in the US market.
Read the full article. Published: 6/28/2011
-
MediStim ASA invites you to a presentation of the first quarter results for 2011 and status for the company.
Read the full article. Published: 4/26/2011
-
MediStim ASA is giving notice of ordinary general meeting the 28th of April 2011. The meeting starts at 09.00 and is held in the company's offices in Fernanda Nissensgate 3 in Oslo. Attached is the agenda for the meeting and attendance form. Attached is also the annual report for 2010.
Read the full article. Published: 4/26/2011
-
MediStim is developing, manufacturing and selling medical equipment which is applied to measure blood flow during surgical procedures, including coronary artery bypass surgery, by the principle of transit time flow measurement. MediStim has several flowmeters on the market, known by the trade names Cardiomed, Butterfly, VeriQ and VeriQC.
Read the full article. Published: 1/25/2011